E09.36 Drug or chemical induced diabetes mellitus with diabetic cataract

Name of the Condition

• Drug or Chemical Induced Diabetes Mellitus with Diabetic Cataract (ICD-10 Code: E09.36)

Summary

Drug or chemical induced diabetes mellitus with diabetic cataract is a condition where elevated blood sugar levels, caused by exposure to specific medications or chemicals, lead to cataract formation. This form of diabetes is directly attributable to external factors that disrupt glucose metabolism, resulting in hyperglycemia and associated lens opacity. The cataract is a direct complication of uncontrolled hyperglycemia, which alters lens metabolism and protein structure.

Causes

The condition is caused by exposure to drugs or chemicals that impair glucose regulation, leading to uncontrolled hyperglycemia. Common culprits include medications (e.g., glucocorticoids, antipsychotics, or diuretics) and toxins that reduce insulin secretion or increase insulin resistance. These substances trigger hyperglycemia, which, if untreated, progresses to diabetic cataract due to osmotic changes and oxidative stress in the lens.

Risk Factors

• Use of medications known to affect glucose metabolism (e.g., steroids, antiretrovirals).
• Exposure to chemicals or toxins that disrupt endocrine function.
• Pre-existing metabolic conditions that increase susceptibility to drug-induced effects.
• Prolonged or high-dose exposure to the causative agent.
• Poorly controlled blood sugar levels, which accelerate lens damage.

Symptoms

• Progressive clouding or blurring of vision.
• Increased sensitivity to glare or light.
• Difficulty seeing in low-light conditions.
• Frequent changes in eyeglass or contact lens prescription.
• Double vision in one eye.

Diagnosis

Diagnosis involves confirming hyperglycemia linked to drug or chemical exposure and identifying cataract formation. Clinical evaluation includes a detailed medication history, blood glucose testing, and ophthalmic examination (e.g., slit-lamp assessment) to detect lens opacity. Imaging or additional tests may be used to rule out other causes of cataract.

Treatment Options

• Managing the underlying hyperglycemia by discontinuing or adjusting the causative agent.
• Blood sugar control through diet, exercise, or medication.
• Surgical removal of the cataract (phacoemulsification) if vision is significantly impaired.
• Postoperative care to maintain glycemic control and prevent complications.

Prognosis and Follow-Up

Prognosis depends on timely intervention and glycemic control. Cataract surgery often restores vision, but recurrent hyperglycemia may lead to new lens changes. Regular follow-up with an ophthalmologist and endocrinologist is essential to monitor vision and blood sugar levels.

Complications

• Progressive vision loss if cataract is untreated.
• Increased risk of other diabetic eye complications (e.g., retinopathy).
• Delayed wound healing after cataract surgery if hyperglycemia persists.

Lifestyle & Prevention

• Avoid or minimize exposure to known glucose-disrupting medications/chemicals when possible.
• Maintain strict blood sugar control through diet and exercise.
• Regular eye examinations to detect early cataract changes.
• Use protective eyewear to reduce additional lens stress.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden vision changes, persistent blurring, or difficulty with daily activities due to vision impairment. Prompt evaluation is critical to prevent irreversible damage.

Tips for Medical Coders

Document the causative drug or chemical exposure and confirm the diagnosis of diabetic cataract. Ensure the code E09.36 is used only when the cataract is directly attributable to drug or chemical-induced diabetes, with clear clinical correlation between the exposure and the ocular complication.